Galectin-3 as a Candidate Marker of Endocrine-modulator-associated Endometrial Remodeling During Breast Cancer Endocrine Therapy
In Vivo · 2026-11 · 40 (6) · 3519-3539
DOI: 10.21873/invivo.14494 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, online erschienen am 29.10.2026. Verfasst von Adamantia Kontogeorgi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, University of Crete, Heraklion, Greece; adamantia.kondogewrgi@gmail.com. Hauptthemen laut MEDLINE: Galectin 3, Endometrium, Antineoplastic Agents, Hormonal, Breast Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School, University of Crete, Heraklion, Greece; adamantia.kondogewrgi@gmail.com.
- Breast Unit, Rea Maternity Hospital, Athens, Greece.
- Independent Authority of Public Revenue, Athens, Greece.
- 1 Department of Pathology, General Hospital of Athens "Laiko", Medical School, National and Kapodistrian University of Athens, Athens, Greece.
- 1 Department of Propedeutic Surgery, General Hospital of Athens "Laiko", Medical School, National and Kapodistrian University of Athens, Athens, Greece.
- 1 Department of Pediatrics, Medical School, General Hospital of Athens "Agia Sofia", Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Zitieren
APA
Kontogeorgi, A., Boutas, I., Kalaitzis, D., Driva, T. S., Agrogiannis, G., Zoumakis, E., Kalantaridou, S. N., & Makrigiannakis, A. (2026). Galectin-3 as a Candidate Marker of Endocrine-modulator-associated Endometrial Remodeling During Breast Cancer Endocrine Therapy. In Vivo, 40(6), 3519-3539. https://doi.org/10.21873/invivo.14494
Vancouver
Kontogeorgi A, Boutas I, Kalaitzis D, Driva TS, Agrogiannis G, Zoumakis E, et al. Galectin-3 as a Candidate Marker of Endocrine-modulator-associated Endometrial Remodeling During Breast Cancer Endocrine Therapy. In Vivo. 2026;40(6):3519-3539. doi:10.21873/invivo.14494
BibTeX
@article{Kontogeorgi2026,
author = {Kontogeorgi, Adamantia and Boutas, Ioannis and Kalaitzis, Dimitrios and Driva, Tatiana S and Agrogiannis, George and Zoumakis, Emmanouil and Kalantaridou, Sophia N and Makrigiannakis, Antonios},
title = {Galectin-3 as a Candidate Marker of Endocrine-modulator-associated Endometrial Remodeling During Breast Cancer Endocrine Therapy},
journal = {In Vivo},
year = {2026},
volume = {40},
number = {6},
pages = {3519--3539},
doi = {10.21873/invivo.14494}
}
EUVIMED